Coronavirus vaccine czar reluctantly decides to forego windfall stock profits after earlier claiming “no conflict of interest”
05/27/2020 / By Ethan Huff
Moncef Slaoui, the so-called coronavirus vaccine “czar” who President Trump recently appointed to head up the next phase of the plandemic, has decided not to accept a massive financial windfall from stock options he owns in Moderna, the company manufacturing a new vaccine.
Some $3.4 million in fresh profits that came on the heels of Slaoui’s new position at the White House sparked massive controversy, resulting in a company announcement that Slaoui has now divested all of his equity interest at Moderna.
After earlier stating that his financial ties to Moderna in no way represent a conflict of interest with regard to his new appointment, Slaoui has since backtracked and is now trying to lay low to avoid any further negative exposure.
“Dr. Slaoui is divesting all of his equity interest in Moderna so that there is no conflict of interest with Dr. Slaoui in his new role,” the company said in a statement that directly conflicts with Slaoui’s earlier claims. And as for the $3.4 million that Slaoui has already received, Moderna claims that the vaccine czar is planning to donate all of it to an unnamed cancer charity.
Up until his recent appointment at the White House, Slaoui sat on the board of directors of Moderna, which in and of itself represents a serious conflict of interest. He also used to work for GlaxoSmithKline (GSK), the same drug giant that was found guilty of committing crimes against humanity.
Listen below to The Health Ranger Report as Mike Adams, the Health Ranger, discusses how many mainstream conservatives who used to believe in vaccines are now becoming vaccine skeptics as they watch all of this corruption unfold:
Trump remains surrounded by Big Pharma swamp creatures
To put it simply, Slaoui is a Big Pharma swamp creature. His wealth came off the backs of innocent people everywhere who have been duped into taking expensive and ineffective drugs and vaccines produced by the various corporations he has worked for over the years.
Slaoui currently holds a whopping 156,000 stock options in Moderna, which no matter how he tries to spin it is a major conflict of interest in that Moderna is developing a vaccine for the Wuhan coronavirus (COVID-19) that Slaoui will be tasked with deciding whether or not to approve.
Since Slaoui and his buddies stand to personally benefit from him choosing Moderna’s vaccine over any other rival vaccine when that time comes, you can almost be certain that Moderna’s is the vaccine that gullible Americans will be lining up to get in the not-too-distant future.
While it might seem easy to chalk it all up to more Big Pharma corruption, the real perpetrator in all of this is Trump. Trump paved the way for Slaoui to slither his way into this top position in a classic display of corporate-government fascism, and he deserves all of the blame for once again lying to the American public about “draining the swamp.”
This latest move by Trump illustrates that this populist politician is not yet reforming the system like he initially hoped. Instead, Trump remains surrounded by swamp creatures from Big Pharma and other industries.
“You could hurt or kill millions of people,” warns Peter Maybarduk of Public Citizen, a watchdog group that sees serious problems with Trump’s pick of Slaoui for this top White House position. “A better vaccine might not be created or it might not be distributed to the widest number of people.”
To keep up with the latest news about the Wuhan coronavirus (COVID-19), be sure to check out Pandemic.news.
Sources for this article include:
Tagged Under:
RECENT NEWS & ARTICLES
